Platelet Fcγ RIIA: An emerging regulator and biomarker in cardiovascular disease and cancer

被引：2
|
作者：
Zhang, Qingsong [1 ]
Li, Wenxian [1 ]
Mao, Xin [1 ]
Miao, Shuo [2 ]
机构：
[1] Qingdao Univ, Affiliated Hosp, Dept Urol, Qingdao, Peoples R China
[2] Qingdao Univ, Sch Basic Med, Qingdao, Peoples R China
来源：
THROMBOSIS RESEARCH | 2024年 / 238卷
关键词：
Platelet; Fc gamma RIIA; Cardiovascular disease; cancer; MONOCLONAL-ANTIBODIES; RECEPTOR EXPRESSION; IMMUNE-COMPLEXES; IMMUNOGLOBULIN-G; TRANSGENIC MICE; ACTIVATION; THROMBOSIS; COLLAGEN; BINDING; IDENTIFICATION;
D O I：
10.1016/j.thromres.2024.04.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Platelets, anucleate blood cells derive from megakaryocytes, are involved in cardiovascular diseases and tumors. Fc gamma RIIA, the only Fc gamma R expressed on human platelets, is known for its role in immune-related diseases. A growing body of evidence reveals that platelet Fc gamma RIIA is a potential target for the prevention and control of cardiovascular disease and cancer, and is an advantageous biomarker. In this review, we describe the structure and physiological function of platelet Fc gamma RIIA, its regulatory role in cardiovascular disease and cancer, and its potential clinical application.
引用
收藏
页码：19 / 26
页数：8
相关论文
共 50 条
  • [21] Platelet FcγRIIA is capable of binding and internalizing IgG complexes.
    Worth, RG
    Chien, P
    O'Reilly, MP
    McKenzie, SE
    Schreiber, AD
    BLOOD, 2001, 98 (11) : 519A - 519A
  • [22] Human platelet FcγRIIA and phagocytes in immune-complex clearance
    Huang, Zhen-Yu
    Chien, Paul
    Indik, Zena K.
    Schreiber, Alan D.
    MOLECULAR IMMUNOLOGY, 2011, 48 (04) : 691 - 696
  • [23] Platelet FcγRIIA binds and internalizes IgG-containing complexes
    Worth, Randall G.
    Chien, Christopher D.
    Chien, Paul
    Reilly, Michael P.
    McKenzie, Steven E.
    Schreiber, Alan D.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (11) : 1490 - 1495
  • [24] Potential role of platelet FcγRIIA in collagen-mediated platelet activation associated with atherothrombosis
    Calverley, DC
    Brass, E
    Hacker, MR
    Tsao-Wei, DD
    Espina, BM
    Pullarkat, VA
    Hodis, HN
    Groshen, S
    ATHEROSCLEROSIS, 2002, 164 (02) : 261 - 267
  • [25] The FcγRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIbα and FcγRIIa and a risk for thromboembolism in lupus anticoagulant patients
    Schallmoser, K
    Rosin, C
    Knittelfelder, R
    Sailer, T
    Ulrich, S
    Zoghlami, C
    Lehr, S
    Pabinger, I
    Panzer, S
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (03) : 544 - 548
  • [26] The human platelet Fc receptor Fc gamma RIIA: Structural requirements for association with Syk kinase in signaling
    Pan, XQ
    Indik, ZK
    Kim, MK
    Chien, P
    Hunter, S
    Schreiber, AD
    THROMBOSIS AND HAEMOSTASIS, 1997, : P3116 - P3116
  • [27] Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner
    Moriarty, R. D.
    Cox, A.
    McCall, M.
    Smith, S. G. J.
    Cox, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (04) : 797 - 806
  • [28] The Parallel Signaling Pathways Of Phosphatidylserine (PS) Exposure Downstream Of Platelet FcγRIIa
    Andre, Pierrette
    McKenzie, Steven E.
    Bergmeier, Wolfgang
    BLOOD, 2013, 122 (21)
  • [29] Association of FcγRIIa and FcγRIIa polymorphisms with clinical outcome in metastatic colorectal cancer patients (mCRC) treated with cetuximab and irinotecan
    Bibeau, F.
    Crapez, E.
    Di Fiore, F.
    Thezenas, S.
    Sabourin, J.
    Lamy, A.
    Frebourg, T.
    Michel, P.
    Ychou, M.
    Boissiere-Michot, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Correlation of platelet FcγRIIA polymorphism in refractory idiopathic (immune) thrombocytopenic purpura
    Williams, Y
    Lynch, S
    McCann, S
    Smith, O
    Feighery, C
    Whelan, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (04) : 779 - 782
12345